10.7861/clinmedicine.5-3-219
Journal article
2005-01-01T00:00:00+00:00
5
219 - 222
3
Antirheumatic Agents, Clinical Trials as Topic, Humans, Receptors, Tumor Necrosis Factor, Rheumatoid Factor, Spondylarthritis, Treatment Outcome, Tumor Necrosis Factor-alpha